Recent Insider Transactions - Janux Therapeutics (NASDAQ: JANX)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ JANX Janux Therapeutics

Meyer Andrew Hollman / officer: Chief Business Officer

04/21/2025

Sell

$4.21

3,334

$14K

90,665

NASDAQ JANX Janux Therapeutics

Meyer Andrew Hollman / officer: Chief Business Officer

04/21/2025

Buy

$4.21

3,334

$14K

85,473

NASDAQ JANX Janux Therapeutics

Meyer Andrew Hollman / officer: Chief Business Officer

04/21/2025

Sell

$30.00

3,334

$100K

82,139

NASDAQ JANX Janux Therapeutics

RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:

03/07/2025

Buy

$31.02

110,206

$3.419M

10.14M

NASDAQ JANX Janux Therapeutics

RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:

03/06/2025

Buy

$30.78

372,093

$11.453M

10.03M

NASDAQ JANX Janux Therapeutics

RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:

03/05/2025

Buy

$31.30

37,455

$1.172M

9.66M

NASDAQ JANX Janux Therapeutics

RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:

03/05/2025

Buy

$30.56

304,287

$9.299M

9.62M

NASDAQ JANX Janux Therapeutics

Meyer Andrew Hollman / officer: Chief Business Officer

03/03/2025

Sell

$4.21

3,334

$14K

93,999

NASDAQ JANX Janux Therapeutics

Meyer Andrew Hollman / officer: Chief Business Officer

03/03/2025

Buy

$4.21

3,334

$14K

85,473

NASDAQ JANX Janux Therapeutics

Meyer Andrew Hollman / officer: Chief Business Officer

03/03/2025

Sell

$31.88

2,433

$78K

83,040

NASDAQ JANX Janux Therapeutics

Meyer Andrew Hollman / officer: Chief Business Officer

03/03/2025

Sell

$32.85

901

$30K

82,139